Product Information
HYDROXYZINE 10 MG/5 ML SYRUP is a generic product labeled by PAI Holdings LLC, priced at $0.1132 per ML under NDC 00121103416. Its NADAC has been published 80 times since Mar 26, 2025.
FDA first approved this application on Apr 10, 2002. Its Orange Book therapeutic-equivalence code is AA.
Strength
10 mg/5mL
Manufacturer
PAI Holdings LLCNDC
00121103416
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROXYZINE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040391FDA Approved
4/10/2002
TE Code
AA
On Market Since
4/10/2002
Pharmacological Classes
Price Statistics
The NADAC for HYDROXYZINE 10 MG/5 ML SYRUP has been published 80 times since Mar 26, 2025, and over the history we have for it it has declined 26.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1132 per ML |
|---|---|
| All-time high | $0.1860 (Jul 16, 2025) |
| All-time low | $0.1089 (Aug 19, 2026) |
| 52-week high | $0.1609 |
| 52-week low | $0.1089 |
| Median price | $0.1327 |
| Average price | $0.1427 |
| Largest weekly change | -11.3% (Oct 22, 2025) |
| Weeks tracked | 80 |
| Tracking since | Mar 26, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the hydroxyzine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
PAI Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
hydroxyzine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antihistamine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROXYZINE 10 MG/5 ML SYRUP?
The current National Average Drug Acquisition Cost (NADAC) for HYDROXYZINE 10 MG/5 ML SYRUP, manufactured by PAI Holdings LLC, is $0.1132 per ML (NDC 00121103416), effective Sep 30, 2026.
How has the price of HYDROXYZINE 10 MG/5 ML SYRUP changed over time?
Over the history we have for it, the NADAC for HYDROXYZINE 10 MG/5 ML SYRUP has declined 26.3%. It has been tracked across 80 weekly CMS publications since Mar 26, 2025.
What are the highest and lowest recorded NADAC prices for HYDROXYZINE 10 MG/5 ML SYRUP?
Since Mar 26, 2025, the NADAC for HYDROXYZINE 10 MG/5 ML SYRUP has ranged from a low of $0.1089 (Aug 19, 2026) to a high of $0.1860 (Jul 16, 2025), with a median of $0.1327 per ML.
Are there cheaper alternatives to HYDROXYZINE 10 MG/5 ML SYRUP?
No other NADAC-published product currently shares the active ingredient and strength of HYDROXYZINE 10 MG/5 ML SYRUP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROXYZINE 10 MG/5 ML SYRUP?
HYDROXYZINE 10 MG/5 ML SYRUP (NDC 00121103416) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.